TGFB1 and coronary artery disorder: Tashiro et al observed that lower TGF-β1 levels were associated with increased risk of long-term major adverse cardiovascular events (MACE), suggesting that plasma levels of this citokyne may have prognostic significance in patients with CAD [14].